These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 27543007)
1. Angiotensin converting enzyme inhibitors and walking distance: Have we walked the whole distance? Vlachopoulos C; Terentes-Printzios D; Aboyans V; Brodmann M; De Carlo M; Tousoulis D Atherosclerosis; 2016 Sep; 252():199-200. PubMed ID: 27543007 [No Abstract] [Full Text] [Related]
2. Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials. Shahin Y; Mazari F; Chetter I Int J Surg; 2011; 9(3):209-13. PubMed ID: 21195215 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication. Shahin Y; Barnes R; Barakat H; Chetter IC Atherosclerosis; 2013 Dec; 231(2):283-90. PubMed ID: 24267241 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease. Hunter MR; Cahoon WD; Lowe DK Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767 [TBL] [Abstract][Full Text] [Related]
5. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460. Kurklinsky AK; Levy M Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841 [TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication. Shahin Y; Cockcroft JR; Chetter IC Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829 [TBL] [Abstract][Full Text] [Related]
7. ACP Journal Club. Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication. Jaar BG Ann Intern Med; 2013 Jun; 158(12):JC7. PubMed ID: 23778931 [No Abstract] [Full Text] [Related]
8. Ramipril improves walking times and quality of life in patients with stable intermittent claudication. Brittenden J Evid Based Med; 2014 Feb; 19(1):16. PubMed ID: 23842688 [No Abstract] [Full Text] [Related]
9. Ramipril for treatment of intermittent claudication. Poredos P Vasa; 2013 Jul; 42(4):237-8. PubMed ID: 23823855 [No Abstract] [Full Text] [Related]
10. Medications for improving walking performance in peripheral artery disease: still miles to go. McDermott MM JAMA; 2013 Feb; 309(5):487-8. PubMed ID: 23385276 [No Abstract] [Full Text] [Related]
11. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271 [TBL] [Abstract][Full Text] [Related]
12. Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients. Ahimastos AA; Dart AM; Lawler A; Blombery PA; Kingwell BA J Hypertens; 2008 May; 26(5):1037-42. PubMed ID: 18398348 [TBL] [Abstract][Full Text] [Related]
14. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663 [TBL] [Abstract][Full Text] [Related]
15. A Three Month Home Exercise Programme Augmented with Nordic Poles for Patients with Intermittent Claudication Enhances Quality of Life and Continues to Improve Walking Distance and Compliance After One Year. Oakley C; Spafford C; Beard JD Eur J Vasc Endovasc Surg; 2017 May; 53(5):704-709. PubMed ID: 28365377 [TBL] [Abstract][Full Text] [Related]
16. The effect of supervised exercise therapy for intermittent claudication on lower limb lean mass. Vun SV; Miller MD; Delaney CL; Allan RB; Spark JI J Vasc Surg; 2016 Dec; 64(6):1763-1769. PubMed ID: 27633168 [TBL] [Abstract][Full Text] [Related]
17. Changes in pain-free walking based on time in accommodating pain-free exercise therapy for peripheral arterial disease. Martinez CA; Carmeli E; Barak S; Stopka CB J Vasc Nurs; 2009 Mar; 27(1):2-7. PubMed ID: 19217538 [TBL] [Abstract][Full Text] [Related]
18. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication. Ahimastos AA; Latouche C; Natoli AK; Reddy-luthmoodoo M; Golledge J; Kingwell BA Circ Res; 2014 Mar; 114(7):1144-55. PubMed ID: 24397981 [TBL] [Abstract][Full Text] [Related]
19. Minimally Important Difference of the Absolute and Functional Claudication Distance in Patients with Intermittent Claudication. van den Houten MM; Gommans LN; van der Wees PJ; Teijink JA Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):404-9. PubMed ID: 26715076 [TBL] [Abstract][Full Text] [Related]
20. Short-term change in distance walked in 6 min is an indicator of outcome in patients with chronic heart failure in clinical practice. Passantino A; Lagioia R; Mastropasqua F; Scrutinio D J Am Coll Cardiol; 2006 Jul; 48(1):99-105. PubMed ID: 16814655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]